Tirzepatide Results: What to Expect Average weight loss of 20-22% of total body weight over 72 weeks Significant improvements in A1c, blood pressure, lipid panels, and inflammatory markers Many patients lose 30-50+ pounds within the first 6-9 months Sustained results with proper maintenance protocols Individual results vary based on starting weight, adherence, lifestyle factors, and dosing
Certain medications also combine GLP-1 action with hormones like Tirzepatide, which work by targeting both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
While the initial results of clinical trials are promising, the long-term efficacy and sustainability of GLP-1 analogue treatments depend on the adoption of healthy lifestyle changes
The risks depend on the contraindication
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023)